1160 related articles for article (PubMed ID: 11155659)
1. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
2. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
Gómez-Lus ML; García Y; Valero E; Amores R; Fuentes F
Rev Esp Quimioter; 2000 Sep; 13(3):306-13. PubMed ID: 11086282
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
7. Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
Knudsen JD; Fuursted K; Espersen F; Frimodt-Møller N
Antimicrob Agents Chemother; 1997 Sep; 41(9):1910-5. PubMed ID: 9303383
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
10. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
11. Activity of the new quinolone WCK 771 against pneumococci.
Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF
Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
[TBL] [Abstract][Full Text] [Related]
13. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 1998 Apr; 41(4):451-9. PubMed ID: 9598776
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
16. [Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].
Reinert RR; Lütticken R; Kaufhold A
Med Klin (Munich); 1993 Jun; 88(6):357-61. PubMed ID: 8336662
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic resistance in pneumococci].
Moreillon P; Wenger A
Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
[TBL] [Abstract][Full Text] [Related]
18. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.
Knudsen JD; Frimodt-Møller N; Espersen F
Antimicrob Agents Chemother; 1995 Jun; 39(6):1253-8. PubMed ID: 7574511
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
Andes D; Craig WA
Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
